Showing 101 - 120 results of 237 for search '"Russian Federation"', query time: 0.07s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105
  6. 106
  7. 107
  8. 108
  9. 109
  10. 110

    Practical Recommendations of Scientific Society for the Study of Human Microbiome and Russian Gastroenterological Association (RGA) for Probiotics in Treatment and Prevention of Ga... by V. T. Ivashkin, I. V. Mayev, D. I. Abdulganieva, S. A. Alekseenko, N. Yu. Ivashkina, N. V. Korochanskaya, S. N. Mammaev, E. A. Poluektova, A. S. Trukhmanov, Yu. P. Uspensky, V. V. Tsukanov, O. S. Shifrin, O. Yu. Zolnikova, K. V. Ivashkin, T. L. Lapina, R. V. Maslennikov, A. I. Ulyanin

    Published 2020-05-01
    “…Probiotics can be registered in the Russian Federation as biologically active food additives (BAFA) or as pharmaceutical products (drugs) in accordance with the microbiological standards and legislative requirements of the Russian Federation. …”
    Get full text
    Article
  11. 111
  12. 112

    Epidemiologic features of non-alcoholic fatty liver disease in Russia by O. M. Drapkina, V. T. Ivashkin

    Published 2014-10-01
    “…The prevalence of NAFLD among adult population of the Russian Federation was 27%, including 80,3% of hepatic steatosis cases, 16,8% — nonalcoholic steatohepatitis and 2,9% — liver cirrhosis. …”
    Get full text
    Article
  13. 113
  14. 114
  15. 115
  16. 116
  17. 117

    Innovative Approach to the Optimal Distribution of Citizens’ Pension Savings to Non-State Pension Funds by Evgeniy Kostyrin, Stepan Drynkin

    Published 2025-02-01
    “…In the Russian Federation, persistent economic and legal tensions surround the allocation of citizens’ pension savings; however, individuals retain the option to select the organization that manages the funded portion of their pension. …”
    Get full text
    Article
  18. 118

    Principles of effective out-patient diagnostics of diffuse liver diseases by Komova A. G., M. V. Mayevskaya, V. T. Ivashkin

    Published 2014-11-01
    “…To study prevalence of diffuse liver diseases in the Russian Federation by the example of large industrial city with application of screening tests. …”
    Get full text
    Article
  19. 119
  20. 120